Medical Patent Week
Susan Hasty, Publisher
Table of Contents . . . January 10th, 2010
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Medical Patent Week | Other Publications
Abiomed, Inc. - Journal of the American College of Cardiology Publishes European Study Results for Abiomed Impella 2.5
Acacia Research Corporation - Acacia Subsidiary Licenses Medical Picture Archiving and Communication System PACS Technology to Aspyra
Alnylam Pharmaceuticals, Inc. - Isis and Alnylam Announce Notice of Allowance for New U.S. Patent Application Broadly Covering RNAi Therapeutics
Amgen - Amgen Resolves EPO Patent Dispute With Roche
Aneurysm - Researchers at University of Cincinnati, Medical Department release new data on aneurysm
Applied Technology Holdings, Inc. - Applied Technology Holdings, Inc. Opens New Headquarters in California
athenahealth, Inc. - athenahealth Receives Top National Ranking for Small Physician Practice Category in 2009 KLAS Report for Practice Management Services
Can-Fite BioPharma - Can-Fite BioPharma to Initiate Phase II Clinical Trial with CF101 for the Treatment of Glaucoma
Celgene Corporation - Initial Data from CALGB-Led Study of Treatment with Continuous REVLIMID(R) in Patients with Multiple Myeloma Following Autologous Stem Cell Transplant Reported
Diverticulosis - Studies from Washington University, Medical Department describe new findings in diverticulosis
Forest Laboratories - Forest Laboratories Announces Acquisition of Additional Rights Related to NXL 104, a Novel Broad-Spectrum Beta-Lactamase Inhibitor
LadaTech, LLC - LadaTech Serves Its Complaint in Patent Infringement Lawsuit Against Illumina, Inc.
Licensing Executives Society USA & Canada, Inc. - Licensing Executives Society USA & Canada Warns That Healthcare Reform Could Make the Patient Sicker
Los Alamos National Laboratory - Unique LANL Pathogen Detector Gains Corporate Partner
Mesa Laboratories, Inc. - Mesa Labs Acquires Bottle Cap Testing Business of Vibrac LLC
MiMedx, Inc. - MiMedx Group Announces Launch of its Paradis Vaso Shield Device
Mirna Therapeutics - Mirna Therapeutics, Inc. Appoints Three External Directors to its Board
Mylan Inc. - Mylan Confirms First-to-File Patent Challenge Relating to Vytorin Cholesterol Medication
Response Biomedical Corporation - Response Biomedical Receives Further U.S. Patent and Trademark Office Notice of Allowance for Key Patent
SenditCertified - SenditCertified and GEMMS Partner to Offer Secure Communications between Doctors and Patients
Syracuse University - How do you improve mammogram accuracy? Add noise
Syracuse University - New compounds may control deadly fungal infections
The Bonati Spine Institute - Reports Indicate Back Related Problems Increasing in U.S.
Tripep - Tripep: Tripep's New Rights Offering Oversubscribed
University of California - Davis - Fast, accurate urine test for pneumonia possible, study finds
Viron Therapeutics Inc. - Viron granted U.S. Patents for Organ Transplant and Arthritis Drug Candidates
Xenomics, Inc. - Xenomics' Preliminary Investigation Leads the Company to Believe Sequenom Willfully Manipulated its Down Syndrome Data in its Presentations
Xenomics, Inc. - Xenomics, Inc., and its Subsidiary TrovaGene, Inc., Announce Italian Patent for NPM1 Testing for AML Patients
ARIAD Pharmaceuticals, Inc. - ARIAD Announces Full Enrollment in Phase 3 Succeed Trial Evaluating Ridaforolimus in Patients with Metastatic Sarcomas
Clear One Health Plans, Inc. - Clear One Health Plans Introduces First Medicare Advantage PPO Plan in Region to Offer in-Network Coverage in Central Oregon, Palm Springs, and Phoenix
Derma Sciences, Inc. - Derma Sciences Obtains Exclusive Worldwide Rights to MEDIHONEY(R)
Exergen Corporation - Exergen TemporalScanner Sponsors 'Game Time Temperature' for NFL and College Bowl Games
GenSpera, Inc. - GenSpera Receives Approval to Commence G-202 Phase I Trial at the University of Wisconsin Carbone Cancer Center
Inter Canadian Business Service - BioSpec Global Solutions Inc. target market TOGS 9000 to state and municipal regulatory bodies in U.S. market
Isis Pharmaceuticals, Inc. - Isis Pharmaceuticals to Receive $10 Million From OncoGenex' License of OGX-011 to Teva
PDL BioPharma, Inc. - PDL BioPharma Announces New Licensing Agreement With Eli Lilly
Picarro, Inc. - Picarro Introduces Liaison(TM) Universal Interface
QLT Inc. - QLT Inc. establishes sales force in the United States
Reliv International, Inc. - Reliv International's Carl W. Hastings Elected to Board of the Council for Responsible Nutrition
Research and Markets - Anticoagulants - a Global Market Review
Research and Markets - Digital Radiography - a Global Update of Market Trends & Opportunities
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
